News - BioSante Pharmaceuticals

Filter

Current filters:

BioSante Pharmaceuticals

Popular Filters

Aduro BioTech buys all GVAX assets from BioSante; Aspen in talks to buy Merck unit

05-02-2013

Aduro BioTech, a privately-held, US venture capital backed biotechnology company, says it has acquired…

Aduro BioTechAspen PharmacareBioSante PharmaceuticalsBiotechnologyGenericsGVAXImmunologicalsMerck & CoMergers & AcquisitionsOncologyVaccines

BioSante and ANI Pharma agree all-stock merger

05-10-2012

USA-based BioSante Pharmaceuticals (Nasdaq: BPAX) and privately-held specialty and generic drugmaker…

ANI PharmaceuticalsBioSante PharmaceuticalsGenericsMergers & AcquisitionsPharmaceutical

BioSante Pill-Plus improves sexual desire, arousal

20-03-2012

US drug developer BioSante Pharmaceuticals (Nasdaq: BPAX) says that data from studies of the Pill-Plus…

BioSante PharmaceuticalsLicensingPantarhei BiosciencePharmaceuticalPill-PlusReproductiveResearchWomen's Health

BioSante female libido drug flops in Ph III studies

16-12-2011

its two pivotal Phase III LibiGel (testosterone gel) efficacy trials, joining the list of failures in…

BioSante PharmaceuticalsBiotechnologyLibiGelResearchWomen's Health

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top